DE60124954D1 - Mu-1, ein mitglied der cytokine rezeptor familie - Google Patents
Mu-1, ein mitglied der cytokine rezeptor familieInfo
- Publication number
- DE60124954D1 DE60124954D1 DE60124954T DE60124954T DE60124954D1 DE 60124954 D1 DE60124954 D1 DE 60124954D1 DE 60124954 T DE60124954 T DE 60124954T DE 60124954 T DE60124954 T DE 60124954T DE 60124954 D1 DE60124954 D1 DE 60124954D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor family
- cytokine receptor
- disclosed
- fragments
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56938400A | 2000-05-11 | 2000-05-11 | |
US569384 | 2000-05-11 | ||
PCT/US2001/015395 WO2001085792A2 (en) | 2000-05-11 | 2001-05-11 | Mu-1, member of the cytokine receptor family |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60124954D1 true DE60124954D1 (de) | 2007-01-11 |
DE60124954T2 DE60124954T2 (de) | 2007-09-20 |
Family
ID=24275231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60124954T Expired - Lifetime DE60124954T2 (de) | 2000-05-11 | 2001-05-11 | Mu-1, ein mitglied der cytokine rezeptor familie |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP1787997A1 (de) |
JP (3) | JP2004500845A (de) |
AT (1) | ATE346864T1 (de) |
AU (2) | AU2001263088B2 (de) |
CY (1) | CY1107339T1 (de) |
DE (1) | DE60124954T2 (de) |
DK (1) | DK1353953T3 (de) |
ES (1) | ES2276795T3 (de) |
PT (1) | PT1353953E (de) |
WO (1) | WO2001085792A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057128A (en) | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
ES2629395T3 (es) | 2001-10-04 | 2017-08-09 | Genetics Institute, Llc | Métodos y composiciones para modular la actividad de la interleucina-21 |
WO2003064469A2 (en) * | 2002-02-01 | 2003-08-07 | Bayer Healthcare Ag | Regulation of human hematopoietin receptor-like protein |
MXPA05000655A (es) | 2002-07-15 | 2006-02-22 | Harvard College | Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th). |
EP1449883A1 (de) * | 2003-02-18 | 2004-08-25 | Corus Technology BV | Verpackungslagen aus Polymer mit besseren Trenneigenschaften |
AU2004221876B2 (en) | 2003-03-14 | 2011-05-26 | Cambridge Antibody Technology Limited | Antibodies against human IL-21 receptor and uses therefor |
GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
AR071885A1 (es) | 2008-05-23 | 2010-07-21 | Wyeth Corp | Proteinas de union al receptor de interleuquina 21 |
CA2725154A1 (en) | 2008-05-23 | 2009-11-26 | Wyeth Llc | Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
JP2012504939A (ja) | 2008-09-23 | 2012-03-01 | ワイス・エルエルシー | 架橋結合タンパク質による活性化シグナルの産生を予測するための方法 |
WO2015110930A1 (en) | 2014-01-24 | 2015-07-30 | Pfizer Inc. | Modified interleukin 21 receptor proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057128A (en) * | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
CA2330547A1 (en) * | 1998-06-24 | 1999-12-29 | Chugai Research Institute For Molecular Medicine, Inc. | Novel hemopoietin receptor proteins |
KR20010085838A (ko) * | 1998-09-23 | 2001-09-07 | 리스 데브라 케이. | 사이토킨 리셉터 zalpha11 |
WO2000069880A1 (en) * | 1999-05-18 | 2000-11-23 | Millennium Pharmaceuticals, Inc. | Il-9/il-2 receptor-like molecules and uses thereof |
DE60125543T2 (de) * | 2000-04-05 | 2007-10-04 | Zymogenetics, Inc., Seattle | Löslicher zytokinrezeptor zalpha11 |
-
2001
- 2001-05-11 EP EP06124726A patent/EP1787997A1/de not_active Withdrawn
- 2001-05-11 EP EP01937340A patent/EP1353953B1/de not_active Expired - Lifetime
- 2001-05-11 AT AT01937340T patent/ATE346864T1/de active
- 2001-05-11 PT PT01937340T patent/PT1353953E/pt unknown
- 2001-05-11 AU AU2001263088A patent/AU2001263088B2/en not_active Expired
- 2001-05-11 DE DE60124954T patent/DE60124954T2/de not_active Expired - Lifetime
- 2001-05-11 ES ES01937340T patent/ES2276795T3/es not_active Expired - Lifetime
- 2001-05-11 AU AU6308801A patent/AU6308801A/xx active Pending
- 2001-05-11 DK DK01937340T patent/DK1353953T3/da active
- 2001-05-11 JP JP2001582391A patent/JP2004500845A/ja active Pending
- 2001-05-11 WO PCT/US2001/015395 patent/WO2001085792A2/en active IP Right Grant
-
2007
- 2007-02-20 CY CY20071100239T patent/CY1107339T1/el unknown
-
2008
- 2008-06-19 JP JP2008161010A patent/JP2009019037A/ja active Pending
-
2011
- 2011-12-27 JP JP2011286773A patent/JP5763518B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1353953B1 (de) | 2006-11-29 |
DE60124954T2 (de) | 2007-09-20 |
JP2009019037A (ja) | 2009-01-29 |
AU2001263088C1 (en) | 2001-11-20 |
CY1107339T1 (el) | 2012-12-19 |
ATE346864T1 (de) | 2006-12-15 |
DK1353953T3 (da) | 2007-04-16 |
AU6308801A (en) | 2001-11-20 |
AU2001263088B2 (en) | 2006-07-20 |
EP1787997A1 (de) | 2007-05-23 |
JP5763518B2 (ja) | 2015-08-12 |
JP2012061009A (ja) | 2012-03-29 |
PT1353953E (pt) | 2007-02-28 |
EP1353953A2 (de) | 2003-10-22 |
ES2276795T3 (es) | 2007-07-01 |
JP2004500845A (ja) | 2004-01-15 |
WO2001085792A8 (en) | 2002-05-23 |
WO2001085792A2 (en) | 2001-11-15 |
WO2001085792A3 (en) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE313626T1 (de) | Mu-1, ein mitglied der zytokinrezeptor-familie | |
CY1107339T1 (el) | Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης | |
HK1131744A1 (en) | Toll like receptor 3 antagonists, methods and uses toll | |
IL200404A0 (en) | 191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF | |
NO995458L (no) | Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder | |
NO20054836L (no) | Nogo-reseptorbindingsprotein | |
ATE212055T1 (de) | Östrogen-rezeptor | |
DE69202936D1 (de) | Hochtemperaturfester, keramischer Verbundstoff. | |
DK1141286T3 (da) | Kæde af cytokinreceptorer | |
ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
DE69942803D1 (de) | Rotein änhelt, und dafür kodierende cdns | |
WO2002064630A3 (en) | Il-1 receptor accessory protein | |
EP0879879A3 (de) | Polypeptid-Deformylase 1 (Def1) | |
EP0911409A3 (de) | Deformylase | |
DE60107431D1 (de) | Ein neues mitglied der epha-rezeptor familie | |
EP0913474A3 (de) | DbpA, eine Helikase aus Staphylococcus aureus | |
ATE320496T1 (de) | Testisspezifische, menschliche proteinase, svph1- 8 | |
EP0927763A3 (de) | Neues aroA | |
NO20011961D0 (no) | PRV-1-genet og anvendelsen av dette | |
WO2000037634A3 (en) | Novel polypeptides and nucleic acids encoding same | |
EP0916727A3 (de) | Neues LysS | |
NO905542D0 (no) | Tienobenzoksepin- og naftotiofenderivater, fremgangsmaate og mellomprodukter for fremstilling derav. | |
EP0894862A3 (de) | Neues CysS | |
EP0906957A3 (de) | Lgt Polypeptid | |
EP0915162A3 (de) | Adenin Phosphoribosyltransferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DF-MP, 80333 MUENCHEN |